Amino-PEG4-Val-Cit-PAB-MMAE - CAS 1492056-71-9

Amino-PEG4-Val-Cit-PAB-MMAE - CAS 1492056-71-9 Catalog number: BADC-00958

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Amino-PEG4-Val-Cit-PAB-MMAE is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Category
ADCs Linker
Product Name
Amino-PEG4-Val-Cit-PAB-MMAE
CAS
1492056-71-9
Catalog Number
BADC-00958
Molecular Formula
C69H115N11O17
Molecular Weight
1370.71
Amino-PEG4-Val-Cit-PAB-MMAE

Ordering Information

Catalog Number Size Price Quantity
BADC-00958 -- $--
Inquiry
Description
Amino-PEG4-Val-Cit-PAB-MMAE is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Synonyms
HY-141154; CS-0114459
IUPAC Name
[4-[[(2S)-2-[[(2S)-2-[3-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[(2S)-1-[[(2S)-2-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methylbutanoyl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylcarbamate
Canonical SMILES
CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(C)C(C2=CC=CC=C2)O)OC)OC)N(C)C(C(C)C)C(=O)NC(=O)C(C(C)C)N(C)C(=O)OCC3=CC=C(C=C3)NC(=O)C(CCCNC(=O)N)NC(=O)C(C(C)C)NC(=O)CCOCCOCCOCCOCCN
InChI
InChI=1S/C69H115N11O17/c1-15-46(8)60(54(91-13)41-56(82)80-32-20-24-53(80)62(92-14)47(9)63(84)73-48(10)61(83)50-21-17-16-18-22-50)78(11)58(44(4)5)66(87)77-67(88)59(45(6)7)79(12)69(90)97-42-49-25-27-51(28-26-49)74-64(85)52(23-19-31-72-68(71)89)75-65(86)57(43(2)3)76-55(81)29-33-93-35-37-95-39-40-96-38-36-94-34-30-70/h16-18,21-22,25-28,43-48,52-54,57-62,83H,15,19-20,23-24,29-42,70H2,1-14H3,(H,73,84)(H,74,85)(H,75,86)(H,76,81)(H3,71,72,89)(H,77,87,88)/t46-,47+,48+,52-,53-,54+,57-,58-,59-,60-,61+,62+/m0/s1
InChIKey
LWOCEMRRZJTWLO-SFLKBQQHSA-N
Solubility
10 mm in DMSO
Purity
>98.0%
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.

Amino-PEG4-Val-Cit-PAB-MMAE, a pivotal linker-drug conjugate, is commonly harnessed in the development of antibody-drug conjugates (ADCs) for precision cancer therapy. Here are four key applications presented with heightened perplexity and burstiness:

ADCs Development: Amino-PEG4-Val-Cit-PAB-MMAE plays a crucial role in crafting potent and selective ADCs designed to target specific cancer cells. The linker facilitates the secure attachment of MMAE, a potent cytotoxic agent, to the antibody, enabling targeted delivery to malignant tissues. This strategy not only minimizes systemic toxicity but also maximizes antitumor efficacy, leading to a paradigm shift in cancer treatment precision.

Cancer Research: In the realm of preclinical cancer investigations, this compound stands as a cornerstone for assessing the efficacy and safety of novel ADCs. Utilizing this linker-drug conjugate, researchers conduct comprehensive in vitro and in vivo experiments to evaluate its impact on tumor dynamics and survival rates. The insights gained aid in pinpointing promising ADC candidates for further escalations into clinical development, fueling advancements in personalized oncology care.

Pharmaceutical Analysis: Amino-PEG4-Val-Cit-PAB-MMAE finds its niche in quality control and analytical scrutiny, ensuring the stability and bioactivity of ADCs. Leveraging sophisticated analytical methodologies such as mass spectrometry and HPLC, experts monitor the conjugation efficiency and purity of ADCs with precision. This meticulous oversight guarantees the consistent performance and safety profile of drug candidates, paving the way for reliable therapeutic interventions.

Targeted Drug Delivery Systems: Beyond the realms of cancer therapy, the versatility of Amino-PEG4-Val-Cit-PAB-MMAE extends to tailored drug delivery systems for diverse therapeutic agents. Through conjugating various bioactive molecules to the linker, researchers engineer innovative drug delivery platforms for a spectrum of disease domains. This application broadens the horizons of this compound, ushering in a new era of targeted therapeutic interventions across multifaceted medical landscapes.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Inquiry Basket